OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
4.350
-0.130 (-2.90%)
At close: Sep 15, 2026, 4:00 PM EDT
4.400
+0.050 (1.15%)
After-hours: Sep 15, 2026, 7:30 PM EDT
OmniAb Employees
OmniAb had 89 employees as of December 31, 2025. The number of employees decreased by 25 or -21.93% compared to the previous year.
Employees
89
Change (1Y)
-25
Growth (1Y)
-21.93%
Revenue / Employee
$432,101
Profits / Employee
-$497,416
Market Cap
632.45M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 89 | -25 | -21.93% |
| Dec 31, 2024 | 114 | 8 | 7.55% |
| Dec 31, 2023 | 106 | 11 | 11.58% |
| Dec 31, 2022 | 95 | 21 | 28.38% |
| Sep 30, 2022 | 93 | 23 | 32.86% |
| Jun 30, 2022 | 87 | 17 | 24.29% |
| Dec 31, 2021 | 74 | 4 | 5.71% |
| Sep 30, 2021 | 70 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| REGENXBIO | 371 |
| CorMedix | 191 |
| Allogene Therapeutics | 152 |
| Prime Medicine | 146 |
| Scribe Therapeutics | 82 |
| Assembly Biosciences | 73 |
| Tectonic Therapeutic | 60 |
| Contineum Therapeutics | 51 |
OABI News
- 1 day ago - OmniAb to Host Investor & Analyst Day on October 6, 2026 - Business Wire
- 20 days ago - OmniAb to Participate in Upcoming Investor Conferences - Business Wire
- 4 weeks ago - OmniAb raises FY26 cash and equivalents view to $49M-$53M vs. $37M-$41M - TheFly
- 4 weeks ago - OmniAb Raises 2026 Financial Guidance - Business Wire
- 4 weeks ago - OmniAb announces collaboration and license agreement with Eli Lilly - TheFly
- 4 weeks ago - OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company - Business Wire
- 5 weeks ago - OmniAb Slides: Corporate presentation - Filings
- 5 weeks ago - OmniAb reports Q2 EPS (5c), consensus (13c) - TheFly